Amantadine induced reversible corneal edema

Milind Deogaonkar; Kathy Wilson; Jerrold L Vitek

doi:10.1016/j.jocn.2010.06.010

Amantadine induced reversible corneal edema

Milind Deogaonkar, Kathy Wilson, Jerrold L Vitek

Neurology

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

Amantadine is becoming more commonly used for Parkinson's disease (PD), particularly for its efficacy in treating the drug-induced dyskinesias. Corneal edema is a known but unusual side effect of amantadine therapy, rarely reported in the neurological literature. We report amantadine-induced reversible corneal edema in a patient with advanced PD.

Original language	English (US)
Pages (from-to)	298-299
Number of pages	2
Journal	Journal of Clinical Neuroscience
Volume	18
Issue number	2
DOIs	https://doi.org/10.1016/j.jocn.2010.06.010
State	Published - Feb 1 2011

Keywords

Amantadine
Corneal edema
Drug-induced dyskinesia
Parkinson's disease

Access

10.1016/j.jocn.2010.06.010

OpenUrl availability

Full text

Cite this

@article{2fcc0055976a4b8f8164bac0d1b76c22,

title = "Amantadine induced reversible corneal edema",

abstract = "Amantadine is becoming more commonly used for Parkinson's disease (PD), particularly for its efficacy in treating the drug-induced dyskinesias. Corneal edema is a known but unusual side effect of amantadine therapy, rarely reported in the neurological literature. We report amantadine-induced reversible corneal edema in a patient with advanced PD.",

keywords = "Amantadine, Corneal edema, Drug-induced dyskinesia, Parkinson's disease",

author = "Milind Deogaonkar and Kathy Wilson and Vitek, {Jerrold L}",

year = "2011",

month = feb,

day = "1",

doi = "10.1016/j.jocn.2010.06.010",

language = "English (US)",

volume = "18",

pages = "298--299",

journal = "Journal of Clinical Neuroscience",

issn = "0967-5868",

publisher = "Churchill Livingstone",

number = "2",

}

TY - JOUR

T1 - Amantadine induced reversible corneal edema

AU - Deogaonkar, Milind

AU - Wilson, Kathy

AU - Vitek, Jerrold L

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Amantadine is becoming more commonly used for Parkinson's disease (PD), particularly for its efficacy in treating the drug-induced dyskinesias. Corneal edema is a known but unusual side effect of amantadine therapy, rarely reported in the neurological literature. We report amantadine-induced reversible corneal edema in a patient with advanced PD.

AB - Amantadine is becoming more commonly used for Parkinson's disease (PD), particularly for its efficacy in treating the drug-induced dyskinesias. Corneal edema is a known but unusual side effect of amantadine therapy, rarely reported in the neurological literature. We report amantadine-induced reversible corneal edema in a patient with advanced PD.

KW - Amantadine

KW - Corneal edema

KW - Drug-induced dyskinesia

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=78651431027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651431027&partnerID=8YFLogxK

U2 - 10.1016/j.jocn.2010.06.010

DO - 10.1016/j.jocn.2010.06.010

M3 - Article

C2 - 21163653

AN - SCOPUS:78651431027

SN - 0967-5868

VL - 18

SP - 298

EP - 299

JO - Journal of Clinical Neuroscience

JF - Journal of Clinical Neuroscience

IS - 2

ER -

Amantadine induced reversible corneal edema

Abstract

Keywords

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this